Neoadjuvant Chemo Did Not Improve Disease-Free Survival

• by Andrea Surnit

• May 1, 2026

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

• by Kathryn Wighton

• February 23, 2026

• 3 min

OR Air Setbacks May Not Affect Outcomes

Findings suggest lower ventilation during idle periods may reduce energy use without worsening outcomes.

• by Andrea Surnit

• April 27, 2026

• 2 min

St Mark’s protocol for standardised examination under anaesthesia for rectovaginal fistulae

• by Okocha, M., Rowe, A., Elgendy, K., Thomas, G., Tozer, P., Vaizey, C.

• March 6, 2026